Press Releases Moderna, Inc.

Equities

MRNA

US60770K1079

Real-time Estimate Cboe BZX Other stock markets 10:22:45 2024-06-10 am EDT			5-day change	1st Jan Change
144.7 ^USD	-4.20%		-1.97%	+45.72%

03:18pm	Moderna's Combination Flu, COVID-19 Shot Triggers High Immune Responses in Late-stage Study	MT
02:44pm	Moderna's Combined Influenza, COVID-19 Shot Elicits 'Higher Immune Response' Versus Others, Drugmaker Says	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

FDA Approves Moderna's MRESVIA Vaccine	10:12am	AQ
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	10:01am	BU
Moderna : The Potential Impact of Combination Vaccines on Public Health	08:50am	PU
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA	Jun. 07	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA	Jun. 07	PR
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines	Jun. 05	AQ
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	Jun. 03	BU
Moderna : ASCO 2024 (Adjuvant melanoma)	Jun. 03	PU
Moderna : ASCO 2024 Trial in Progress (melanoma)	Jun. 03	PU
Moderna : ASCO 2024 Trial in Progress (NSCLC)	Jun. 03	PU
Patents, Policies And Privacy: The Highs And Lows Of Technology In IP	May. 31	AQ
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns	May. 30	AQ
Moderna Announces Data to be presented at 2024 ASCO Annual Meeting	May. 23	AQ
SA Covid-19 Vaccine Negotiation Records Show Pharma Bullying Amidst Pandemic [press release]	May. 22	AQ
Moderna Announces Update on Investigational RSV Vaccine	May. 13	AQ
Moderna Litigation Against BioNTech And Pfizer Stayed Pending IPR	May. 06	AQ
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates	May. 03	AQ
Moderna: Q1 Earnings Snapshot	May. 02	AQ
Moderna : 2024 ESCMID (mRNA-1010)	Apr. 30	PU
Moderna : Licenses COVID-19-related Intellectual Property to a Pharmaceutical Company in Japan	Apr. 29	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Moderna, Inc. prepares for the post-Covid era

March 25, 2024 at 10:24 am EDT

Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector

January 16, 2024 at 03:31 pm EST